MesoTV Podcast: Conversations Impacting the Mesothelioma Community
En podcast av Mesothelioma Applied Research Foundation
39 Avsnitt
-
MesoTV: The surgical approach to meso and how genetics impact treatment
Publicerades: 2021-12-14 -
Radiation and immunotherapy: emerging mechanisms of synergy w/ Dr. Breen from Mayo Clinic
Publicerades: 2021-11-09 -
Chemotherapy + immunotherapy, another positive step in mesothelioma treatment
Publicerades: 2021-11-09 -
”Does staging matter in mesothelioma” with Dr. James Stevenson of the Cleveland Clinic
Publicerades: 2021-10-01 -
Pneumonitis in immunotherapy-treated mesothelioma patients
Publicerades: 2021-09-30 -
Peritoneal mesothelioma surgery and treatment at the National Cancer Institute
Publicerades: 2021-09-30 -
Toxicities, side-effects, from immunotherapy for treatment of mesothelioma
Publicerades: 2021-07-13 -
CLINICAL TRIAL: Engineered T-cell therapy (TC-210, gavo-cel) for mesothelioma
Publicerades: 2021-06-11 -
CLINICAL TRIAL: Neoadjuvant Immune Checkpoint Blockade in Resectable Malignant Pleural Mesothelioma
Publicerades: 2021-05-25 -
Current trends in mesothelioma treatment - discussion by thought-leaders in this disease
Publicerades: 2021-05-20 -
Pain management for mesothelioma patients from a multi-disciplinary perspective
Publicerades: 2021-05-18 -
Discussion of mesothelioma patients who underwent an EPP (extrapleural pneumonectomy - lung removal)
Publicerades: 2021-02-03 -
Clinical trial assessing the addition of IMRT to pemetrexed (Alimta)/platinum based therapy
Publicerades: 2021-01-26 -
Vaccination Considerations for Mesothelioma Patients
Publicerades: 2021-01-13 -
Dr. Paul Sugarbaker discusses HIPEC in peritoneal mesothelioma
Publicerades: 2021-01-11 -
Mesothelioma Patients Discuss "Chemo Brain"
Publicerades: 2021-01-07 -
Inherited Genetics and Mesothelioma
Publicerades: 2021-01-06 -
Life After Mesothelioma Treatment Community Panel
Publicerades: 2021-01-06 -
FDA's Expanded Access and Compassionate Use Rules' Impact on Mesothelioma Treatment
Publicerades: 2021-01-06
The Mesothelioma Applied Research Foundation developed MesoTV in response to the need to cancel our annual International Symposium on Malignant Mesothelioma. In our first season we covered a number of topics, many focused on the immediate effects of Covid-19 on mesothelioma treatment. In our second season and beyond, we focus on more traditional topics such as advances in treatment, mesothelioma science, the patient and caregiver experience and quality of life. The Mesothelioma Applied Research Foundation is the only nonprofit charity organization dedicated to ending mesothelioma, and the suffering caused by this cancer, by: funding research to improve treatment options; providing treatment support and education for patients and their families; and advocating for federal funding of research.
